CyPHR AI Engine Arrives: Cygenex Bridges Gap Between Genomics and Education

New AI-powered health assistant translates genetic data into personalized guidance.

Apr. 1, 2026 at 12:03am

Got story updates? Submit your updates here. ›

Cygenex, a leader in precision medicine, has launched CyPHR, an AI-powered health assistant designed to convert an individual's genetic data into actionable, real-time clinical guidance. CyPHR aims to eliminate trial-and-error medicine by providing personalized insights on medication risks, lifestyle choices, and preventive interventions.

Why it matters

CyPHR represents a significant advancement in the application of pharmacogenomics, bridging the gap between genetic insights and everyday healthcare decisions. By empowering individuals with a deeper understanding of their biology, CyPHR enables a shift from reactive care to proactive, precision-driven intervention.

The details

CyPHR replaces the traditional trial-and-error prescribing model by cross-referencing genetic data with current medications to educate individuals on potential risks and adverse interactions. The AI-powered assistant synthesizes genetic, lifestyle, and health data to provide 24/7 personalized guidance, identify potential risks early, and support preventive interventions.

  • CyPHR was launched on March 31, 2026.

The players

Cygenex

A leader in precision medicine and pharmacogenomic risk optimization, Cygenex developed CyPHR as an AI-powered health assistant.

Charles Clark

The CEO of Cygenex, who stated that CyPHR transforms static genetic data into a dynamic, real-time education tool that provides individuals insights into their path to better health.

Sharyl Loggins

The VP of Technology at Cygenex, who said that CyPHR is about educating individuals on their genetic profile and putting precision medicine directly into their hands.

Got photos? Submit your photos here. ›

What they’re saying

“For decades, healthcare has operated without visibility into one of the most critical variables, individual biology. CyPHR changes that. It transforms static genetic data into a dynamic, real-time education tool that provides individuals insights into their path to better health.”

— Charles Clark, CEO

“CyPHR is not just about testing. It's about educating individuals on their genetic profile. We are putting precision medicine directly into the hands of the individual.”

— Sharyl Loggins, VP of Technology

What’s next

Cygenex plans to continue expanding the capabilities of CyPHR to further bridge the gap between genomics and everyday healthcare decisions.

The takeaway

CyPHR represents a significant step towards a future where healthcare is predictive and treatment decisions are informed by individual biology, not guesswork. By empowering individuals with personalized genetic insights, CyPHR aims to drive measurable improvements in health outcomes and reduce the inefficiencies of trial-and-error medicine.